Administration of drug through nasal route is an alternative of parenteral route which is also known as nasal drug delivery system. The nasal drug administration has been used as an alternative route for the systemic availability of drugs that are restricted to intravenous administration. This technology provides easy to administration, patient compliance, low dose requirement, bypass first pass metabolism, excellent penetration rapid absorption and gives desirable effects. Many drug delivery devices for nasal application of liquid, semisolid and solid formulation are investigated to deliver the drugs to the treat most CNS diseases such as, Parkinson's disease and Alzheimer's disease.
MARKET DYNAMICS
The nasal drug delivery technology market is anticipated to grow in the forecast period owing to driving factors such as, increasing demand for nasal drug delivery systems, technological advancement and growing incidence of chronic diseases. Moreover, growing adoption of self-administration practices is anticipated to offer more growth opportunities for the players operating in the nasal drug delivery technology market.
MARKET SCOPE
The "Global Nasal Drug Delivery Technology Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of nasal drug delivery technology market with detailed market segmentation by systems, containers, dosage form, therapeutic application, end user and geography. The global nasal drug delivery technology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading nasal drug delivery technology market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global nasal drug delivery technology market is segmented on the basis of systems, containers, dosage form, therapeutic application and end user. Based on systems, the market is segmented as, unit dose, bi-dose and multi dose. On the basis of containers, the market is segmented into, pressurized containers and non-pressurized containers. Based on the dosage form, the nasal drug delivery technology market is classified as, nasal powders, nasal gels, nasal drops & liquids and nasal spray. On the basis of application, the global nasal drug delivery technology market is categorized as, allergic & non-allergic rhinitis, nasal congestion, vaccinations and other applications. Based on the end user, the global nasal drug delivery technology market is segmented into hospitals and home health care.
(image)
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global nasal drug delivery technology market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The nasal drug delivery technology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting nasal drug delivery technology market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the nasal drug delivery technology market in these regions.
(image)
MARKET PLAYERSThe reports cover key developments in the nasal drug delivery technology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from nasal drug delivery technology market are anticipated to lucrative growth opportunities in the future with the rising demand for nasal drug delivery technology market in the global market. Below mentioned is the list of few companies engaged in the nasal drug delivery technology market.
The report also includes the profiles of key nasal drug delivery technology market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
• Novartis AG
• Pfizer, Inc.
• Merck and Co., Inc.
• Glaxosmithkline PLC
• Johnson and Johnson Services, Inc.
• 3M
• BD
• Astrazeneca PLC
• Aegis Therapeutics, LLC
• Aptargroup, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
(image)